The purpose of this study is to test 2 different dosing regimens of GW433908/ritonavir (RTV) versus lopinavir (LPV)/RTV when each is given with 2 active reverse transcriptase inhibitors (RTIs), in patients who have taken anti-HIV drugs without success.
Patients will receive 2 dosing regimens of GW433908/RTV or LPV/RTV, in combination with 2 active RTIs, after failing their first or second protease inhibitor-containing regimen. Patients are required to be on therapy at time of screening and must remain on this therapy until Day 1.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Enrollment
330
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Phoenix Body Positive
Phoenix, Arizona, United States
Ocean View Internal Medicine
Long Beach, California, United States
Bisher Akil
Los Angeles, California, United States
Tower ID Med Associates
Los Angeles, California, United States
Orange Coast Med Group
Newport Beach, California, United States
Pacific Horizons Med Group
San Francisco, California, United States
Denver Inf Disease Consultants
Denver, Colorado, United States
Physicans Home Service
Washington D.C., District of Columbia, United States
IDC Research Initiative
Altamonte Springs, Florida, United States
Bach and Godofsky
Bradenton, Florida, United States
...and 22 more locations